These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34312401)

  • 1. A new strategy to uncover fragile X proteomic biomarkers using the nascent proteome of peripheral blood mononuclear cells (PBMCs).
    Dionne O; Corbin F
    Sci Rep; 2021 Jul; 11(1):15148. PubMed ID: 34312401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of protein synthesis are reduced in peripheral blood mononuclear cells (PBMCs) from fragile X individuals.
    Dionne O; Lortie A; Gagnon F; Corbin F
    PLoS One; 2021; 16(5):e0251367. PubMed ID: 33974659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.
    Van Dijck A; Barbosa S; Bermudez-Martin P; Khalfallah O; Gilet C; Martinuzzi E; Elinck E; Kooy RF; Glaichenhaus N; Davidovic L
    BMC Neurol; 2020 Apr; 20(1):138. PubMed ID: 32295518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights of altered lipid profile in Fragile X Syndrome.
    Çaku A; Seidah NG; Lortie A; Gagné N; Perron P; Dubé J; Corbin F
    PLoS One; 2017; 12(3):e0174301. PubMed ID: 28334053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.
    Tang B; Wang T; Wan H; Han L; Qin X; Zhang Y; Wang J; Yu C; Berton F; Francesconi W; Yates JR; Vanderklish PW; Liao L
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4697-706. PubMed ID: 26307763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke.
    Bian F; Simon RP; Li Y; David L; Wainwright J; Hall CL; Frankel M; Zhou A
    Stroke; 2014 Apr; 45(4):1177-9. PubMed ID: 24558093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
    Hoeffer CA; Sanchez E; Hagerman RJ; Mu Y; Nguyen DV; Wong H; Whelan AM; Zukin RS; Klann E; Tassone F
    Genes Brain Behav; 2012 Apr; 11(3):332-41. PubMed ID: 22268788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
    Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
    Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Profiling of Brain and Testis Reveals the Diverse Changes in Ribosomal Proteins in fmr1 Knockout Mice.
    Xu B; Zhang Y; Zhan S; Wang X; Zhang H; Meng X; Ge W
    Neuroscience; 2018 Feb; 371():469-483. PubMed ID: 29292077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Analysis Identifies Key Molecular Signatures Underlying Neurodevelopmental Deficits in Fragile X Syndrome.
    Utami KH; Skotte NH; Colaço AR; Yusof NABM; Sim B; Yeo XY; Bae HG; Garcia-Miralles M; Radulescu CI; Chen Q; Chaldaiopoulou G; Liany H; Nama S; Peteri UA; Sampath P; Castrén ML; Jung S; Mann M; Pouladi MA
    Biol Psychiatry; 2020 Sep; 88(6):500-511. PubMed ID: 32653109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS).
    Zafarullah M; Jasoliya M; Tassone F
    Cells; 2020 Oct; 9(10):. PubMed ID: 33027907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model.
    Davidovic L; Navratil V; Bonaccorso CM; Catania MV; Bardoni B; Dumas ME
    Genome Res; 2011 Dec; 21(12):2190-202. PubMed ID: 21900387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder.
    Saldarriaga W; Payán-Gómez C; González-Teshima LY; Rosa L; Tassone F; Hagerman RJ
    J Dev Behav Pediatr; 2020 Dec; 41(9):724-728. PubMed ID: 32947579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.